Cargando…

Serum lipopolysaccharides predict advanced liver disease in the general population

BACKGROUND & AIMS: Gut-derived endotoxemia has been implicated in the development of chronic liver disease, but its relevance at the population level remains unclear. We analyzed whether endotoxemia is associated with incident advanced liver disease in the general population. METHODS: Serum lipo...

Descripción completa

Detalles Bibliográficos
Autores principales: Männistö, Ville, Färkkilä, Martti, Pussinen, Pirkko, Jula, Antti, Männistö, Satu, Lundqvist, Annamari, Valsta, Liisa, Salomaa, Veikko, Perola, Markus, Åberg, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005654/
https://www.ncbi.nlm.nih.gov/pubmed/32039385
http://dx.doi.org/10.1016/j.jhepr.2019.09.001
_version_ 1783494983023591424
author Männistö, Ville
Färkkilä, Martti
Pussinen, Pirkko
Jula, Antti
Männistö, Satu
Lundqvist, Annamari
Valsta, Liisa
Salomaa, Veikko
Perola, Markus
Åberg, Fredrik
author_facet Männistö, Ville
Färkkilä, Martti
Pussinen, Pirkko
Jula, Antti
Männistö, Satu
Lundqvist, Annamari
Valsta, Liisa
Salomaa, Veikko
Perola, Markus
Åberg, Fredrik
author_sort Männistö, Ville
collection PubMed
description BACKGROUND & AIMS: Gut-derived endotoxemia has been implicated in the development of chronic liver disease, but its relevance at the population level remains unclear. We analyzed whether endotoxemia is associated with incident advanced liver disease in the general population. METHODS: Serum lipopolysaccharide (LPS) was measured in 6,727 (3,455 male and 3,272 female, mean age 53.4 ± 10.9 years, mean body mass index 27.2 ± 4.5) individuals participating in the Finnish population-based health examination survey FINRISK 1997. Data were linked with electronic health registers for incident advanced liver disease (hospitalization, cancer or death related to liver disease). During a mean follow-up of 16.3 ± 3.8 years (109,282 person-years), 86 liver events occurred. Univariate and multivariate Cox regression, and Kaplan-Meier analyses were performed. RESULTS: Serum LPS predicted incident advanced liver disease with a hazard ratio per 1 SD of 1.41 (95% CI 1.24–1.59; p ≪0.001) when adjusted for age, sex, gamma-glutamyltransferase, metabolic syndrome, alcohol use, patatin-like phospholipase domain-containing protein 3 (PNPLA3) I148M, waist-hip ratio and type 2 diabetes. This association remained robustly significant in additional multivariate analyses with various levels of adjustment. The association was accentuated among carriers of the PNPLA3 risk variant. The population attributable fraction of the highest LPS tertile for liver events was 29.7%. However, LPS was not associated with all-cause mortality. CONCLUSION: Serum LPS is associated with hospitalization, cancer or death related to liver disease in the general population, with the highest tertile potentially accounting for 30% of the risk of liver disease. LAY SUMMARY: Lipopolysaccharide, a gut-derived bacterial endotoxin, has been implicated in the development of chronic liver disease, but its relevance at the population level remains unclear. We found that serum lipopolysaccharide levels were associated with incident advanced liver disease in the general population, with the highest tertile accounting for up to 30% of the risk of hospitalization, cancer or death related to liver disease.
format Online
Article
Text
id pubmed-7005654
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-70056542020-02-07 Serum lipopolysaccharides predict advanced liver disease in the general population Männistö, Ville Färkkilä, Martti Pussinen, Pirkko Jula, Antti Männistö, Satu Lundqvist, Annamari Valsta, Liisa Salomaa, Veikko Perola, Markus Åberg, Fredrik JHEP Rep Research Article BACKGROUND & AIMS: Gut-derived endotoxemia has been implicated in the development of chronic liver disease, but its relevance at the population level remains unclear. We analyzed whether endotoxemia is associated with incident advanced liver disease in the general population. METHODS: Serum lipopolysaccharide (LPS) was measured in 6,727 (3,455 male and 3,272 female, mean age 53.4 ± 10.9 years, mean body mass index 27.2 ± 4.5) individuals participating in the Finnish population-based health examination survey FINRISK 1997. Data were linked with electronic health registers for incident advanced liver disease (hospitalization, cancer or death related to liver disease). During a mean follow-up of 16.3 ± 3.8 years (109,282 person-years), 86 liver events occurred. Univariate and multivariate Cox regression, and Kaplan-Meier analyses were performed. RESULTS: Serum LPS predicted incident advanced liver disease with a hazard ratio per 1 SD of 1.41 (95% CI 1.24–1.59; p ≪0.001) when adjusted for age, sex, gamma-glutamyltransferase, metabolic syndrome, alcohol use, patatin-like phospholipase domain-containing protein 3 (PNPLA3) I148M, waist-hip ratio and type 2 diabetes. This association remained robustly significant in additional multivariate analyses with various levels of adjustment. The association was accentuated among carriers of the PNPLA3 risk variant. The population attributable fraction of the highest LPS tertile for liver events was 29.7%. However, LPS was not associated with all-cause mortality. CONCLUSION: Serum LPS is associated with hospitalization, cancer or death related to liver disease in the general population, with the highest tertile potentially accounting for 30% of the risk of liver disease. LAY SUMMARY: Lipopolysaccharide, a gut-derived bacterial endotoxin, has been implicated in the development of chronic liver disease, but its relevance at the population level remains unclear. We found that serum lipopolysaccharide levels were associated with incident advanced liver disease in the general population, with the highest tertile accounting for up to 30% of the risk of hospitalization, cancer or death related to liver disease. Elsevier 2019-10-23 /pmc/articles/PMC7005654/ /pubmed/32039385 http://dx.doi.org/10.1016/j.jhepr.2019.09.001 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Männistö, Ville
Färkkilä, Martti
Pussinen, Pirkko
Jula, Antti
Männistö, Satu
Lundqvist, Annamari
Valsta, Liisa
Salomaa, Veikko
Perola, Markus
Åberg, Fredrik
Serum lipopolysaccharides predict advanced liver disease in the general population
title Serum lipopolysaccharides predict advanced liver disease in the general population
title_full Serum lipopolysaccharides predict advanced liver disease in the general population
title_fullStr Serum lipopolysaccharides predict advanced liver disease in the general population
title_full_unstemmed Serum lipopolysaccharides predict advanced liver disease in the general population
title_short Serum lipopolysaccharides predict advanced liver disease in the general population
title_sort serum lipopolysaccharides predict advanced liver disease in the general population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005654/
https://www.ncbi.nlm.nih.gov/pubmed/32039385
http://dx.doi.org/10.1016/j.jhepr.2019.09.001
work_keys_str_mv AT mannistoville serumlipopolysaccharidespredictadvancedliverdiseaseinthegeneralpopulation
AT farkkilamartti serumlipopolysaccharidespredictadvancedliverdiseaseinthegeneralpopulation
AT pussinenpirkko serumlipopolysaccharidespredictadvancedliverdiseaseinthegeneralpopulation
AT julaantti serumlipopolysaccharidespredictadvancedliverdiseaseinthegeneralpopulation
AT mannistosatu serumlipopolysaccharidespredictadvancedliverdiseaseinthegeneralpopulation
AT lundqvistannamari serumlipopolysaccharidespredictadvancedliverdiseaseinthegeneralpopulation
AT valstaliisa serumlipopolysaccharidespredictadvancedliverdiseaseinthegeneralpopulation
AT salomaaveikko serumlipopolysaccharidespredictadvancedliverdiseaseinthegeneralpopulation
AT perolamarkus serumlipopolysaccharidespredictadvancedliverdiseaseinthegeneralpopulation
AT abergfredrik serumlipopolysaccharidespredictadvancedliverdiseaseinthegeneralpopulation